2000
DOI: 10.1016/s1074-5521(00)00076-4
|View full text |Cite
|
Sign up to set email alerts
|

Novel octaketide macrolides related to 6-deoxyerythronolide B provide evidence for iterative operation of the erythromycin polyketide synthase

Abstract: The isolation of novel DEBS-derived octaketides provides the first evidence that an extension module in a modular PKS has the potential to catalyse iterative rounds of chain elongation like other type I FAS and PKS systems. The factors governing the extent of such 'stuttering' remain to be determined.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
62
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 78 publications
(62 citation statements)
references
References 45 publications
0
62
0
Order By: Relevance
“…The programmed iteration of extension‐module 1 on the AZL PKS occurs, as with previously identified examples of programmed iteration of modules,11, 26 at a point in the assembly line where there is a protein–protein interface27 (here between AzlA and AzlB). Those previous examples all involve the same level of β‐keto processing in each of the iterative rounds of chain elongation.…”
mentioning
confidence: 53%
See 1 more Smart Citation
“…The programmed iteration of extension‐module 1 on the AZL PKS occurs, as with previously identified examples of programmed iteration of modules,11, 26 at a point in the assembly line where there is a protein–protein interface27 (here between AzlA and AzlB). Those previous examples all involve the same level of β‐keto processing in each of the iterative rounds of chain elongation.…”
mentioning
confidence: 53%
“…An early example is the pikromycin PKS, which produces both a 12‐membered and a 14‐membered macrolide through optional “skipping”10 of a PKS module. In other examples, a single extension module catalyzes two or more successive (and identical) rounds of polyketide carbon skeleton, either to give aberrant products11 or as part of the normal biosynthetic pathway 12, 13, 14, 15, 16. These exceptions promise to increase our understanding of the natural evolution of modular PKSs, and potentially offer lessons for the effective engineering of these systems.…”
mentioning
confidence: 99%
“…For example, 16-membered erythromycins were isolated from Saccharopolyspora erythraea, as a result of aberrant repeated use (termed PKS stuttering) of 6-deoxyerythronolide B synthases [2]. In contrast, ringcontracted epothilone derivatives were isolated as a result of PKS skipping in addition to ring-enlarged derivatives [3].…”
Section: Introductionmentioning
confidence: 99%
“…Details of the genetic engineering, product isolation, and characterization and of the insight obtained into the operation of the biosynthetic pathway are described elsewhere. The isolation of stutt-6-dEB and Ac-stutt-6-dEB has been described [13]. GlaxoSmithKline kindly provided approximately 200 mg of each of these two products (purity 85%) for use in the experiments reported.…”
Section: Methodsmentioning
confidence: 99%
“…These compounds are produced by the aberrant function of the erythromycin PKS [13] and are identical to 6-dEB except that a 3-carbon unit, (boxed in Scheme 2) has been incorporated twice. This phenomenon has been referred to as "stuttering" [13] and consequently, these compounds are referred to as stuttered 6-dEB (stutt-6-dEB) (Structure 4) and acetate starter stuttered 6-dEB (Acstutt-6-dEB) (Structure 6) and to the 3-carbon unit as the "stuttered unit". The study of these compounds was important because they have been fully characterized by 2-D NMR spectroscopy and thus provided further solid evidence upon which to predict the structure of a novel 16-membered macrolide aglycone as stutt-EB (Structure 5).…”
mentioning
confidence: 99%